Northern Trust’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.61M | Sell |
588,830
-32,472
| -5% | -$365K | ﹤0.01% | 2312 |
|
|
2025
Q1 | $2.84M | Sell |
621,302
-29,260
| -4% | -$134K | ﹤0.01% | 2737 |
|
|
2024
Q4 | $3.67M | Buy |
650,562
+73,295
| +13% | +$413K | ﹤0.01% | 2694 |
|
|
2024
Q3 | $2.79M | Buy |
577,267
+5,044
| +0.9% | +$24.4K | ﹤0.01% | 2792 |
|
|
2024
Q2 | $2.79M | Sell |
572,223
-8,559
| -1% | -$41.8K | ﹤0.01% | 2722 |
|
|
2024
Q1 | $7.71M | Buy |
580,782
+87,492
| +18% | +$1.16M | ﹤0.01% | 2210 |
|
|
2023
Q4 | $6.88M | Buy |
493,290
+26,968
| +6% | +$376K | ﹤0.01% | 2315 |
|
|
2023
Q3 | $6.18M | Buy |
466,322
+8,084
| +2% | +$107K | ﹤0.01% | 2313 |
|
|
2023
Q2 | $8.59M | Buy |
458,238
+54,675
| +14% | +$1.03M | ﹤0.01% | 2172 |
|
|
2023
Q1 | $5.82M | Buy |
403,563
+3,700
| +0.9% | +$53.4K | ﹤0.01% | 2366 |
|
|
2022
Q4 | $7.74M | Buy |
399,863
+10,947
| +3% | +$212K | ﹤0.01% | 2184 |
|
|
2022
Q3 | $13.4M | Buy |
388,916
+108,001
| +38% | +$3.71M | ﹤0.01% | 1777 |
|
|
2022
Q2 | $4.29M | Buy |
280,915
+1,416
| +0.5% | +$21.6K | ﹤0.01% | 2614 |
|
|
2022
Q1 | $6.38M | Buy |
279,499
+134,914
| +93% | +$3.08M | ﹤0.01% | 2434 |
|
|
2021
Q4 | $5.33M | Buy |
144,585
+4,494
| +3% | +$166K | ﹤0.01% | 2637 |
|
|
2021
Q3 | $6.58M | Buy |
+140,091
| New | +$6.58M | ﹤0.01% | 2562 |
|